Investment
Features
FeesSafety
Academy
More
Pluang+

Compare First Citizens BancShares Inc (FCNCA) vs Nomura Holdings Inc (NMR) Price & Performance

First Citizens BancShares IncTrade
Nomura Holdings IncTrade

Price performance (Past 24H)

Key statistics

First Citizens BancShares Inc vs Nomura Holdings Inc — how do they compare? First Citizens BancShares Inc trades at $2,069.1 (market cap $22.94B), while Nomura Holdings Inc trades at $9.58 (market cap $27.55B). The key difference: Nomura Holdings Inc is the larger of the two by market cap, and Nomura Holdings Inc pays the higher dividend (3.4%). Which is the better fit depends on your goals — on Pluang, investors hold First Citizens BancShares Inc for 29 Days and Nomura Holdings Inc for 55 Days on average.

FCNCANMR
Market Cap
$22.94B$27.55B
Volume
91,668782,470
Sector
Sector/ThematicFinancials
52-Week High
$2.29K$10.86
52-Week Low
$1.64K$6.73
Typical Hold Time
29 Days55 Days
Dividend Yield
0.41%3.4%
Enterprise Value
—$38.54T

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

First Citizens BancShares Inc

First Citizens BancShares (FCNCA) trades at $2,071.56, down 0.79% on the day, with a bearish technical signal driven by moving averages. The stock shows strong fundamentals, with a P/E of 11.11 and net income margin of 25.23%, and has beaten EPS estimates for the last three quarters. Recent corporate actions include a $2.10 dividend and expansion through branch acquisitions and new financing initiatives.

The outlook is mixed: solid profitability and earnings beats support upside toward the $2,290 consensus price target, but near-term technical weakness and high institutional hold ratings suggest caution. Key risks include execution of growth initiatives and broader economic pressures on banking.

Nomura Holdings Inc

Nomura Holdings (NMR) trades at $9.57, showing modest daily gains of 0.42%. The stock presents a mixed technical picture with bearish moving averages but oversold RSI readings. Fundamentally, NMR demonstrates strong profitability with 20.4% net margins and attractive valuation metrics including a P/E of 11.33 and P/B of 1.15. Recent earnings show volatility with two misses and one beat in the last four quarters. The company maintains robust revenue growth, reaching $1.66 trillion in 2025 with expanding profit margins.

NMR offers value investment appeal with reasonable valuations and solid profitability, though technical weakness and inconsistent earnings performance present near-term challenges. The stock's current oversold condition combined with strong fundamental metrics suggests potential for recovery, but investors should monitor earnings consistency and debt levels that have been trending upward. Analyst sentiment remains cautiously optimistic with a buy rating consensus despite recent technical pressure.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FCNCA

No sentiment data available yet.

NMR
0% Buy100% Sell
Avg holding period · 55 Days

Top news

Latest headlines on both assets

About First Citizens BancShares Inc

First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.

Read more on FCNCA →

About Nomura Holdings Inc

Nomura is Japan's largest broker, about twice the size of rival Daiwa Securities and roughly three times the size of the securities units of the three megabanks. It is also the largest asset-management company in Japan, with a similar size differential compared with its rivals. Despite its topnotch brand name in retail broking and asset management in Japan, Nomura has struggled to compete effectively in the institutional securities business against larger global rivals. In 2008, Nomura bought European and Asian assets of the failed Lehman Brothers, which led to a sharply higher cost base but did not provide commensurate revenue. Nomura has reduced the scale of these businesses but maintains its ambition to compete globally with the top players.

Read more on NMR →